Impact of viable CD45 cells infused on lymphocyte subset recovery after unrelated cord blood transplantation in children

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 1, 2011, Pages 109-116

  Barlogis, Vincent ^a   Glasman, Laurence ^b   Brunet, Corine ^b   Loundou, Anderson Dieudonne ^c   Lemarie, Claude ^d   Galambrun, Claire ^a   Thuret, Isabelle ^a   Curtillet, Catherine ^a   Le Meignen, Marion ^a   Bernard, Fanette ^a   Chambost, Herve ^a   Calmels, Boris ^d   Picard, Christophe ^e   Chabannon, Christian ^d   Dignat George, Francoise ^b   Michel, Gerard ^a  

^a TIMONE HOSPITAL   (France)

^b HÔPITAL DE LA CONCEPTION   (France)

^c Department of Public Health   (France)

^d INSTITUT PAOLI CALMETTES   (France)

^e ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

THYMOCYTE ANTIBODY; CD45 ANTIGEN; LEUKOCYTE ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; B LYMPHOCYTE; CD19+ T LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD45+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SELECTION; CELL VIABILITY; CHILD; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; INFANT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MYELOABLATIVE CONDITIONING; NATURAL KILLER CELL; NEOPLASM; NEWBORN; OUTCOME ASSESSMENT; PREMEDICATION; PRESCHOOL CHILD; PROGNOSIS; SCHOOL CHILD; T LYMPHOCYTE; CELL COUNT; CELL SURVIVAL; CYTOLOGY; GRAFT SURVIVAL; HEMATOLOGIC DISEASE; IMMUNOLOGY; IMMUNOPHENOTYPING; KINETICS; LYMPHOCYTE SUBPOPULATION; METHODOLOGY;

ADOLESCENT; ANTIGENS, CD; ANTIGENS, CD45; CELL COUNT; CELL SURVIVAL; CHILD; CHILD, PRESCHOOL; CORD BLOOD STEM CELL TRANSPLANTATION; GRAFT SURVIVAL; HEMATOLOGIC DISEASES; HUMANS; IMMUNOPHENOTYPING; INFANT; KINETICS; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS;

EID: 79956225222     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.06.016     Document Type: Article

References (46)

1. Kurtzberg J, Laughlin M, Graham ML, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med. 1996;335:157-166.
2. Wagner JE, Rosenthal J, Sweetman R, et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood. 1996;88:795-802.
3. Gluckman E, Rocha V, Boyer-Chammard A, et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med. 1997;337:373-381.
4. Grewal SS, Barker JN, Davies SM, Wagner JE. Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood? Blood. 2003;101:4233-4244.
5. Rocha V, Cornish J, Sievers EL, et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood. 2001;97:2962-2971.
6. Eapen M, Rubinstein P, Zhang MJ, et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet. 2007;369:1947-1954.
7. Kurtzberg J, Prasad VK, Carter SL, et al. Results of the Cord Blood Transplantation study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood. 2008;112: 4318-4327.
8. Laughlin MJ, Eapen M, Rubinstein P, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med. 2004;351: 2265-2275.
9. Shi-Xia X, Xian-Hua T, Xiang-Feng T. Unrelatedumbilical cord blood transplantation and unrelated bonemarrowtransplantation in children with hematological disease: a meta-analysis. Pediatr Transplant. 2009;13:278-284.
10. Rocha V, Wagner JE Jr., Sobocinski KA, et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med. 2000;342:1846-1854.
11. Barker JN, Davies SM, DeFor T, Ramsay NK, Weisdorf DJ, Wagner JE. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood. 2001;97:2957-2961.
12. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med. 1998;339:1565-1577.
13. Barker JN, Hough RE, van Burik JA, et al. Serious infections after unrelated donor transplantation in 136 children: impact of stem cell source. Biol Blood Marrow Transplant. 2005;11:362-370.
14. Rocha V, Gluckman E. Clinical use of umbilical cord blood hematopoietic stem cells. Biol Blood Marrow Transplant. 2006;12:34-41.
15. Long GD, Laughlin M, Madan B, et al. Unrelated umbilical cord blood transplantation in adult patients. Biol Blood Marrow Transplant. 2003;9:772-780.
16. Thomson BG, Robertson KA, Gowan D, et al. Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation. Blood. 2000;96:2703-2711.
17. Giraud P, Thuret I, Reviron D, et al. Immune reconstitution and outcome after unrelated cord blood transplantation: a single paediatric institution experience. Bone Marrow Transplant. 2000;25:53-57.
18. Moretta A, Maccario R, Fagioli F, et al. Analysis of immune reconstitution in children undergoing cord blood transplantation. Exp Hematol. 2001;29:371-379.
19. Knutsen AP, Wall DA. Umbilical cord blood transplantation in severe T-cell immunodeficiency disorders: two-year experience. J Clin Immunol. 2000;20:466-476.
20. Niehues T, Rocha V, Filipovich AH, et al. Factors affecting lymphocyte subset reconstitution after either related or unrelated cord blood transplantation in childrenda Eurocord analysis. Br J Haematol. 2001;114:42-48.
21. Lemarie C, Esterni B, Calmels B, et al. CD34(1) progenitors are reproducibly recovered in thawed umbilical grafts, and positively influence haematopoietic reconstitution after transplantation. Bone Marrow Transplant. 2007;39:453-460.
22. Brocklebank AM, Sparrow RL. Enumeration of CD341 cells in cord blood: a variation on a single-platform flow cytometric method based on the ISHAGE gating strategy. Cytometry. 2001;46:254-261.
23. Keeney M, Chin-Yee I, Weir K, Popma J, Nayar R, Sutherland DR. Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering. Cytometry. 1998;34:61-70.
24. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18:695-706.
25. Fine JP. Regression modeling of competing crude failure probabilities. Biostatistics. 2001;2:85-97.
26. Klein JP, Rizzo JD, Zhang MJ, Keiding N. Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling. Bone Marrow Transplant. 2001;28:1001-1011.
27. Szydlo R. Statistical evaluation of HSCT data. In: Apperley J, Carreras E, Gluckman E, Gratwohl A, Masszi T, editors. The EBMT Handbook, Haematopoietic Stem Cell Transplantation. Forum Service Editore; 2008. p. 328-339.
28. Shearer WT, Rosenblatt HM, Gelman RS, et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol. 2003;112:973-980.
29. Neven B, Leroy S, Decaluwe H, et al. Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency. Blood. 2009;113:4114-4124.
30. Kalwak K, Gorczynska E, Toporski J, et al. Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery. Br J Haematol. 2002;118:74-89.
31. Simpson D. T-cell depleting antibodies: new hope for induction of allograft tolerance in bone marrow transplantation? BioDrugs. 2003;17:147-154.
32. Mackall CL, Bare CV, Granger LA, Sharrow SO, Titus JA, Gress RE. Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheralT cells resulting in a repertoire that is limited in diversity and prone to skewing. J Immunol. 1996;156:4609-4616.
33. Mackall CL, Gress RE. Thymic aging and T-cell regeneration. Immunol Rev. 1997;160:91-102.
34. Talvensaari K, Clave E, Douay C, et al. A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation. Blood. 2002;99:1458-1464.
35. Locatelli F, Rocha V, Chastang C, et al. Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group. Blood. 1999;93:3662-3671.
36. Wagner JE, Barker JN, DeFor TE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood. 2002;100:1611-1618.
37. Hamza NS, Lisgaris M, Yadavalli G, et al. Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults. Br J Haematol. 2004; 124:488-498.
38. Szabolcs P, Niedzwiecki D. Immune reconstitution after unrelated cord blood transplantation. Cytotherapy. 2007;9: 111-122.
39. Gluckman E, Rocha V, Arcese W, et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol. 2004;32:397-407.
40. Jaroscak J, Goltry K, Smith A, et al. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Blood. 2003;101:5061-5067.
41. Devine SM, Lazarus HM, Emerson SG. Clinical application of hematopoietic progenitor cell expansion: current status and future prospects. Bone Marrow Transplant. 2003;31:241-252.
42. Barker JN, Weisdorf DJ, DeFor TE, et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood. 2005;105:1343-1347.
43. Majhail NS, Brunstein CG, Wagner JE. Double umbilical cord blood transplantation. Curr Opin Immunol. 2006;18:571-575.
44. Brunstein CG, Wagner JE, Weisdorf DJ, et al. Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity. Blood. 2009;113:5628-5634.
45. MacMillan ML, Weisdorf DJ, Brunstein CG, et al. Acute graftversus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors. Blood. 2009;113: 2410-2415.
46. Verneris MR, Brunstein CG, Barker J, et al. Relapse risk after umbilical cord blood transplantation: enhanced graft-versusleukemia effect in recipients of 2 units. Blood. 2009;114: 4293-4299